金城医药：目前公司经营情况正常

Core Viewpoint - The company, Jincheng Pharmaceutical, is currently operating normally and is focused on five strategic areas: pharmaceutical chemicals, synthetic biology, women's health technology, high-end anti-infection, and new tobacco products [2] Group 1: Business Operations - The company has established a solid reputation in the industry due to its stable and high-quality product offerings, including AE active ester, cephalosporin active ester, and glutathione raw materials [2] - The company's antibiotic injectables, oral agents, and gynecological oral and topical formulations are recognized for their excellent quality and play significant roles in their respective treatment areas [2] Group 2: Future Outlook - By 2025, multiple products are expected to complete domestic and international registrations, leading to a richer product portfolio and enhanced competitiveness [2] - The company plans to increase market development efforts, actively expand new customers and markets, and continuously promote the growth and operational performance of the company [2]